Growth hormone secretagogues explained: GHRH vs GHRP

Growth hormone secretagogues are peptides that prompt your pituitary gland to release its own growth hormone (GH), rather than supplying GH itself. They fall into two families: GHRH analogues, which copy growth-hormone-releasing hormone, and GHRPs, which act on the ghrelin receptor. Using one from each family together is the standard approach because they act on different receptors and can produce a bigger GH pulse than either alone.

The two families

GHRH analogues

Your hypothalamus releases GHRH, which tells the pituitary to release GH. GHRH analogues mimic that signal. They tend to preserve your body's natural pulsing and feedback, because GH release still runs through the normal pathway. The main ones are:

• Sermorelin: a short fragment of GHRH. It was previously marketed as a medicine in some countries, but is not widely available as one today.
• CJC-1295: a modified GHRH analogue. It comes in two forms. The "no DAC" form (also called modified GRF 1-29) is short-acting. The "with DAC" form is designed to last far longer, which raises a more constant background of GH rather than a pulse.
• Tesamorelin: a stabilised GHRH analogue. Unlike the others here, it is a licensed medicine in some countries, for reducing excess abdominal fat in people with HIV-associated lipodystrophy. Using it for anything else is off-label.

GHRPs (ghrelin-receptor agonists)

Ghrelin is the "hunger hormone", and it also stimulates GH release. GHRPs act on the ghrelin receptor to do the same thing. The main ones are:

• Ipamorelin: generally described as the most selective, with less effect on hunger, cortisol and prolactin than the older GHRPs.
• GHRP-2: a stronger GH release, with more appetite stimulation and some reported rise in cortisol and prolactin.
• GHRP-6: known for pronounced hunger, which some people value and many find unpleasant.
• Hexarelin: among the most potent GH releasers, but associated with faster loss of effect with repeated use (desensitisation) and a more noticeable cortisol and prolactin response.

Why are they used in pairs?

In physiology studies, giving a GHRH and a GHRP together produces a GH release that is greater than the sum of the two alone. The usual explanation is that the two signals reinforce each other at the pituitary, and that a GHRP can also dampen somatostatin, the hormone that puts the brakes on GH release. This synergy is one of the better-established ideas in this area, which is why combinations like CJC-1295 + ipamorelin are the community standard.

Note the limits: these findings come from controlled physiology work and clinical use of individual compounds. They do not show that any particular community stack improves body composition, recovery or ageing in healthy people, and the claims made online go well beyond the evidence.

Pulses, timing and the food problem

The short-acting ones give a single GH pulse per injection, closer to the natural pattern than a long-acting compound or injecting GH itself. Because high blood sugar and insulin blunt GH release, people who use these typically inject fasted or a few hours after eating, and many choose bedtime. These are community conventions, not clinical protocols.

Side effects to know about

• Hunger: especially with GHRP-6 and, to a lesser degree, GHRP-2 and hexarelin. Ipamorelin is usually milder.
• Water retention and swelling: puffy hands and feet, joint aches, tingling or numbness in the fingers (carpal-tunnel-type symptoms), all familiar from raised GH levels.
• Cortisol and prolactin rises: more associated with GHRP-2, GHRP-6 and hexarelin than ipamorelin. These can bring fatigue, mood changes or, in principle, effects on libido and hormones.
• Flushing, headache and dizziness: often right after injection.
• Blood sugar effects: raised GH can reduce insulin sensitivity. This matters most for anyone with diabetes, pre-diabetes or a family history.
• Sleep and mood changes: reported both ways, so there is no reliable rule.
• Injection-site reactions: redness, itching, small lumps.

Raised GH and IGF-1 also raise a longer-term question about cell growth. That is theoretical for most of these compounds because there is little long-term human data, but it is a reason for caution, especially with any history of cancer.

Licensing and sport

Tesamorelin has a specific licensed indication. Sermorelin has had one historically. The rest are sold as research chemicals and are not licensed medicines. Growth hormone secretagogues are prohibited in sport under anti-doping rules, so tested athletes should check the current list.

Quality matters

Under-dosed, contaminated or simply wrong products are a real problem in this market, and it is harder to tell if something is working when the effect is a hormone pulse you cannot feel. See how to spot fake or under-dosed peptides and the safer use guide. If you are working out what you are even trying to achieve, find your goal is a calmer starting point.

Bottom line

GHRH analogues and GHRPs both lead to your own GH release, via different receptors, and pairing one of each is the logic behind most stacks. The synergy is real in physiology studies, but benefits in healthy adults are far less well-established than online claims suggest, side effects such as hunger, water retention and cortisol or prolactin rises are common, and most of these products are unlicensed. If you have any health condition, an endocrinologist is the right person to ask, not a forum.